AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Amphastar Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$26.14+0.27 (+1.04%)
Close on Oct 19, 2026
- Market cap
- $1.16B
- P/E (TTM)
- 15.4
- Dividend yield
- –
SEC filings
40 of Amphastar Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 9, 2026 | Jul 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 2, 2026 | Jul 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 3, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 1, 2026 | Apr 13, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 6, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 6, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2025 | Oct 24, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2025 | Sep 18, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 18, 2025 | Jul 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 2, 2025 | Apr 14, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2025 | Feb 27, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2024 | Aug 30, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 9, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2024 | Jun 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 10, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 3, 2024 | Apr 12, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 29, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2024 | Feb 28, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 8, 2023 | SEC EDGAR |